COMMENSAL BACTERIA AS VECTORS FOR MUCOSAL VACCINES AGAINST SEXUALLY-TRANSMITTED DISEASES - VAGINAL COLONIZATION WITH RECOMBINANT STREPTOCOCCI INDUCES LOCAL AND SYSTEMIC ANTIBODIES IN MICE
D. Medaglini et al., COMMENSAL BACTERIA AS VECTORS FOR MUCOSAL VACCINES AGAINST SEXUALLY-TRANSMITTED DISEASES - VAGINAL COLONIZATION WITH RECOMBINANT STREPTOCOCCI INDUCES LOCAL AND SYSTEMIC ANTIBODIES IN MICE, Vaccine, 15(12-13), 1997, pp. 1330-1337
There is a need to develop vaccines to control the spread of sexually
transmitted diseases (STDs). Novel immunization strategies that elicit
a mucosal immune response in the genital tract, may show improved pro
tection by preventing or at least limiting entry of the pathogenic mic
ro-organism. However, it has proven difficult to obtain a local immune
response in the vaginal mucosa. Our approach is based on the use of r
ecombinant bacteria capable of colonizing mucosal surfaces as live vac
cine vectors. The human commensal Streptococcus gordonii, engineered t
o express the E7 protein of human papillomavirus type 16, was used for
intravaginal immunization of mice. A single inoculum of recombinant b
acteria was sufficient to establish colonization of the murine vagina
and therefore induce papillomavirus-specific vaginal IgA and serum IgG
. Evidence that mucosal colonization with recombinant commensal bacter
ia can induce a local immune response in the female genital tract repr
esents a significant step toward the development of new vaccines again
st STDs. (C) 1997 Elsevier Science Ltd.